These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 28065477)

  • 1. Quantitative analysis of the yield of avian H7 influenza virus haemagglutinin protein produced in silkworm pupae with the use of the codon-optimized DNA: A possible oral vaccine.
    Nerome K; Matsuda S; Maegawa K; Sugita S; Kuroda K; Kawasaki K; Nerome R
    Vaccine; 2017 Feb; 35(5):738-746. PubMed ID: 28065477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The large-scale production of an artificial influenza virus-like particle vaccine in silkworm pupae.
    Nerome K; Sugita S; Kuroda K; Hirose T; Matsuda S; Majima K; Kawasaki K; Shibata T; Poetri ON; Soejoedono RD; Mayasari NL; Agungpriyono S; Nerome R
    Vaccine; 2015 Jan; 33(1):117-25. PubMed ID: 25448101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of a virus-like particle influenza vaccine in Eri silkworm pupae, using Autographa californica nuclear polyhedrosis virus and host-range expansion.
    Maegawa K; Shibata T; Yamaguchi R; Hiroike K; Izzati UZ; Kuroda K; Sugita S; Kawasaki K; Nerome R; Nerome K
    Arch Virol; 2018 Oct; 163(10):2787-2797. PubMed ID: 30027487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prime/boost vaccination with HA DNA and Pichia-produced HA protein elicits a strong humoral response in chickens against H5N1.
    Stachyra A; Pietrzak M; Macioła A; Protasiuk A; Olszewska M; Śmietanka K; Minta Z; Góra-Sochacka A; Kopera E; Sirko A
    Virus Res; 2017 Mar; 232():41-47. PubMed ID: 28159612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective efficacy of baculovirus-derived influenza virus-like particles bearing H5 HA alone or in combination with M1 in chickens.
    Choi JG; Kim MC; Kang HM; Kim KI; Lee KJ; Park CK; Kwon JH; Kim JH; Lee YJ
    Vet Microbiol; 2013 Mar; 162(2-4):623-630. PubMed ID: 23265240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incorporation of conserved nucleoprotein into influenza virus-like particles could provoke a broad protective immune response in BALB/c mice and chickens.
    Xue C; Tian G; Chen X; Liu Q; Ma J; Xu S; Li X; Chen H; Cao Y
    Virus Res; 2015 Jan; 195():35-42. PubMed ID: 25312452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A DNA Vaccine That Targets Hemagglutinin to Antigen-Presenting Cells Protects Mice against H7 Influenza.
    Andersen TK; Zhou F; Cox R; Bogen B; Grødeland G
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28931687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of a recombinant duck enteritis virus (DEV) expressing hemagglutinin of H5N1 avian influenza virus based on an infectious clone of DEV vaccine strain and evaluation of its efficacy in ducks and chickens.
    Wang J; Ge A; Xu M; Wang Z; Qiao Y; Gu Y; Liu C; Liu Y; Hou J
    Virol J; 2015 Aug; 12():126. PubMed ID: 26263920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal vaccination with H5, H7 and H9 hemagglutinins co-localized in a virus-like particle protects ferrets from multiple avian influenza viruses.
    Tretyakova I; Pearce MB; Florese R; Tumpey TM; Pushko P
    Virology; 2013 Jul; 442(1):67-73. PubMed ID: 23618102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mono- and quadri-subtype virus-like particles (VLPs) containing H10 subtype elicit protective immunity to H10 influenza in a ferret challenge model.
    Pushko P; Sun X; Tretyakova I; Hidajat R; Pulit-Penaloza JA; Belser JA; Maines TR; Tumpey TM
    Vaccine; 2016 Oct; 34(44):5235-5242. PubMed ID: 27663671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.
    Pascual E; Mata CP; Gómez-Blanco J; Moreno N; Bárcena J; Blanco E; Rodríguez-Frandsen A; Nieto A; Carrascosa JL; Castón JR
    J Virol; 2015 Mar; 89(5):2563-74. PubMed ID: 25520499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced Influenza Virus-Like Particle Vaccination with a Structurally Optimized RIG-I Agonist as Adjuvant.
    Beljanski V; Chiang C; Kirchenbaum GA; Olagnier D; Bloom CE; Wong T; Haddad EK; Trautmann L; Ross TM; Hiscott J
    J Virol; 2015 Oct; 89(20):10612-24. PubMed ID: 26269188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cocktail of H5N1 COBRA HA vaccines elicit protective antibodies against H5N1 viruses from multiple clades.
    Crevar CJ; Carter DM; Lee KY; Ross TM
    Hum Vaccin Immunother; 2015; 11(3):572-83. PubMed ID: 25671661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pseudotype baculovirus-mediated vaccine confers protective immunity against lethal challenge with H5N1 avian influenza virus in mice and chickens.
    Wu Q; Fang L; Wu X; Li B; Luo R; Yu Z; Jin M; Chen H; Xiao S
    Mol Immunol; 2009 Jul; 46(11-12):2210-7. PubMed ID: 19446339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virus-like particle vaccine conferred complete protection against a lethal influenza virus challenge.
    Galarza JM; Latham T; Cupo A
    Viral Immunol; 2005; 18(2):365-72. PubMed ID: 16035948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal administration of adjuvant-combined recombinant influenza virus HA vaccine protects mice from the lethal H5N1 virus infection.
    Asahi-Ozaki Y; Itamura S; Ichinohe T; Strong P; Tamura S; Takahashi H; Sawa H; Moriyama M; Tashiro M; Sata T; Kurata T; Hasegawa H
    Microbes Infect; 2006 Oct; 8(12-13):2706-14. PubMed ID: 16968669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of influenza H7N9 virus like particle (VLP) vaccine: homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus.
    Smith GE; Flyer DC; Raghunandan R; Liu Y; Wei Z; Wu Y; Kpamegan E; Courbron D; Fries LF; Glenn GM
    Vaccine; 2013 Sep; 31(40):4305-13. PubMed ID: 23891795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination with virus-like particles containing H5 antigens from three H5N1 clades protects chickens from H5N1 and H5N8 influenza viruses.
    Kapczynski DR; Tumpey TM; Hidajat R; Zsak A; Chrzastek K; Tretyakova I; Pushko P
    Vaccine; 2016 Mar; 34(13):1575-1581. PubMed ID: 26868083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.
    Pavlova SP; Veits J; Keil GM; Mettenleiter TC; Fuchs W
    Vaccine; 2009 Jan; 27(5):773-85. PubMed ID: 19041677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and immunogenicity of hemagglutinin from highly pathogenic avian influenza virus H5N1 expressed in Nicotiana benthamiana.
    Pua TL; Chan XY; Loh HS; Omar AR; Yusibov V; Musiychuk K; Hall AC; Coffin MV; Shoji Y; Chichester JA; Bi H; Streatfield SJ
    Hum Vaccin Immunother; 2017 Feb; 13(2):306-313. PubMed ID: 27929750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.